Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of SEK 27.89 billion. The enterprise value is 28.85 billion.

Market Cap	27.89B
Enterprise Value	28.85B

Important Dates

The last earnings date was Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Vitrolife AB has 135.39 million shares outstanding. The number of shares has increased by 0.09% in one year.

Current Share Class	n/a
Shares Outstanding	135.39M
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	74.51%
Float	74.96M

Valuation Ratios

The trailing PE ratio is 54.50 and the forward PE ratio is 38.94. Vitrolife AB's PEG ratio is 2.25.

PE Ratio	54.50
Forward PE	38.94
PS Ratio	7.73
PB Ratio	2.05
P/TBV Ratio	n/a
P/FCF Ratio	39.28
P/OCF Ratio	n/a
PEG Ratio	2.25

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.55, with an EV/FCF ratio of 40.63.

EV / Earnings	56.23
EV / Sales	7.99
EV / EBITDA	23.55
EV / EBIT	36.84
EV / FCF	40.63

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.15.

Current Ratio	3.34
Quick Ratio	2.65
Debt / Equity	0.15
Debt / EBITDA	1.71
Debt / FCF	2.94
Interest Coverage	7.18

Financial Efficiency

Return on equity (ROE) is 3.90% and return on invested capital (ROIC) is 3.20%.

Return on Equity (ROE)	3.90%
Return on Assets (ROA)	2.90%
Return on Invested Capital (ROIC)	3.20%
Return on Capital Employed (ROCE)	4.68%
Revenue Per Employee	3.22M
Profits Per Employee	458,036
Employee Count	1,120
Asset Turnover	0.21
Inventory Turnover	3.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.05% in the last 52 weeks. The beta is 1.79, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.79
52-Week Price Change	+9.05%
50-Day Moving Average	213.08
200-Day Moving Average	215.05
Relative Strength Index (RSI)	45.65
Average Volume (20 Days)	189,715

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of SEK 3.61 billion and earned 513.00 million in profits. Earnings per share was 3.78.

Revenue	3.61B
Gross Profit	2.14B
Operating Income	783.00M
Pretax Income	674.00M
Net Income	513.00M
EBITDA	1.23B
EBIT	783.00M
Earnings Per Share (EPS)	3.78

Full Income Statement

Balance Sheet

The company has 1.14 billion in cash and 2.09 billion in debt, giving a net cash position of -954.00 million or -7.05 per share.

Cash & Cash Equivalents	1.14B
Total Debt	2.09B
Net Cash	-954.00M
Net Cash Per Share	-7.05
Equity (Book Value)	13.64B
Book Value Per Share	100.71
Working Capital	1.65B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 907.00 million and capital expenditures -197.00 million, giving a free cash flow of 710.00 million.

Operating Cash Flow	907.00M
Capital Expenditures	-197.00M
Free Cash Flow	710.00M
FCF Per Share	5.24

Full Cash Flow Statement

Margins

Gross margin is 59.27%, with operating and profit margins of 21.70% and 14.21%.

Gross Margin	59.27%
Operating Margin	21.70%
Pretax Margin	18.68%
Profit Margin	14.21%
EBITDA Margin	33.94%
EBIT Margin	21.70%
FCF Margin	19.67%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.52%.

Dividend Per Share	1.10
Dividend Yield	0.52%
Dividend Growth (YoY)	10.00%
Years of Dividend Growth	2
Payout Ratio	26.32%
Buyback Yield	-0.09%
Shareholder Yield	0.42%
Earnings Yield	1.84%
FCF Yield	2.55%

Dividend Details

Stock Splits

The last stock split was on May 17, 2018. It was a forward split with a ratio of 5.

Last Split Date	May 17, 2018
Split Type	Forward
Split Ratio	5

Scores

Vitrolife AB has an Altman Z-Score of 4.7.

Altman Z-Score	4.7
Piotroski F-Score	n/a